In the news
Takara Bio USA, Inc. (formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., develops, manufactures, and distributes a wide range of life science research reagents under the Takara, Clontech, and Cellartis brands. To keep you up to date with the latest happenings at Takara Bio USA, we have compiled our recent announcements and press releases below.
Automation of Takara Bio’s chemistries on Eppendorf’s automated pipetting systems for significantly higher efficiency
Date: August 28, 2023
Categories: Announcement
Takara Bio Inc. (Takara Bio) and Eppendorf SE, two renowned leaders in the life science industry, are pleased to announce their collaboration through a strategic co-marketing agreement. This partnership aims at jointly developing cutting-edge solutions to automate Takara Bio’s chemistries on Eppendorf epMotion® automation platforms.
Takara Bio is committed to the fight against antimicrobial resistance
Date: December 30, 2022
Categories: Announcement
Access a USA Today article describing solutions that combat the dangerous growth of antimicrobial resistance.
Takara Bio USA, Inc. and BioExcel Diagnostics partner for development of wide-coverage infectious disease detection panels
Date: October 17, 2022
Categories: Press release
BioExcel Diagnostics has partnered with Takara Bio, USA, Inc. to develop and validate wide-coverage infectious disease detection panels using the SmartChip Real-Time PCR System.
Takara Bio announces partnership for the distribution of CE-IVD solutions for respiratory tract infections
Date: September 6, 2022
Takara Bio Europe (TBE) announced a partnership with the German company BioeXsen GmbH for the distribution of in vitro diagnostic solutions for the qPCR detection of common pathogens found in respiratory tract infections.
Takara Bio, Inc expands GMP facility to accommodate a variety of modalities and strengthen supply chain
Date: March 26, 2022
In response to rapidly increasing demands for CDMO services, including manufacturing of gene therapy drugs and vaccines, the new GMP facility expanded its manufacturing capacity. We plan full operation by 2023.
Takara Bio USA wins EU opposition hearing on its foundational NGS library enrichment patent
Date: February 15, 2022
Categories: Press release
Learn how TBUSA’s granted European patent EP 3105325 was upheld by the European Patent Office which confirmed it's validity after an opposition claim was made against it.
Takara Bio USA, Inc. launches automated, full-length single-cell RNA-seq solution for enhanced biomarker discovery
Date: October 18, 2021
Categories: Announcement
Our complete, automated solution for biomarker discovery enables full-length transcriptome profiling on over 1,500 single cells simultaneously.
Takara Bio Europe SAS launches an in vitro diagnostic assay for the detection of SARS-CoV-2
Date: October 5, 2021
Categories: Announcement
Learn more about Takara Bio Europe's in vitro diagnostic assay for the qualitative RT-qPCR-based detection of novel coronavirus (SARS-CoV-2) from patients suspected of having COVID-19.
Takara Bio Europe AB partners with Boston IVF Fertility Clinic for the derivation of clinical-grade hES cell lines
Date: September 20, 2021
Takara Bio Europe's partnership with Boston IVF Fertility Clinic provides them access to discarded starting material for the derivation of clinical-grade hES cell lines for cell therapy research.
Takara Bio Europe AB and PanCryos announce licensing agreement to enable development of cell-based therapy for diabetes
Date: May 6, 2021
Categories: Announcement
The Takara Bio Group of companies and PanCryos are pleased to announce that they have reached a licensing agreement surrounding Takara Bio’s clinical-grade human embryonic stem (hES) cell lines.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2024 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
